This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Borge Teisner: Innovator in Diabetes Diagnosis
Introduction
Borge Teisner is a notable inventor based in Odense, Denmark. He has made significant contributions to the field of diabetes research, particularly in the early diagnosis of insulin-dependent diabetes mellitus. His innovative approach has the potential to improve patient outcomes through early intervention.
Latest Patents
Borge Teisner holds a patent for a method of diagnosing preclinical diabetes. This invention involves determining the T cell response to a specific islet cell antigen known as fetal antigen 1 (FA1) or detecting the presence of autoantibodies against FA1 in serum. The patent also includes a test kit for this method and a pharmaceutical composition of FA1, which can be used for therapy in insulin-dependent diabetes mellitus.
Career Highlights
Teisner is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on innovative solutions that address critical health challenges related to diabetes.
Collaborations
Some of his notable coworkers include Ole Dragsbaek Madsen and Birgitte Koch Michelsen. Their collaborative efforts contribute to the advancement of diabetes research and the development of effective treatment methods.
Conclusion
Borge Teisner's contributions to diabetes diagnosis exemplify the impact of innovation in healthcare. His work not only enhances our understanding of diabetes but also paves the way for improved therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile